By Dr. Helen Rothberg, ACI Faculty
Incredible experience in the Masters of CI courses last week. By Thursday, people’s left brains were getting tired from analytical models and number crunching. In the afternoon, we began scenario analysis, and on Friday, their right brains kicked in and I witnessed integrative thinking from the four previous days of learning […]
It takes a few days walking away from our training to digest all that has been learned. The emotions our students go through during the week are high, and low, excitement, frustration, feeling overwhelmed, and exhaustion. The different faculty also help with those emotions from the excitement of Leonard Fuld, and Ken Sawka to the cranky “Yoda” Ben Gilad and the “Rock Star” Helen Rothberg.
ACI announces an alliance with ACP- American Corporate Partners, a not-for-profit organization helping to connect veterans to corporate mentors. ACP honors us by accepting our training as valuable for former intelligence professionals from government or military agencies.
For years we had to turn down applicants from government or military intelligence jobs who wanted to get a CIP™ […]
Me and the giants. The CI giants, that is. Or maybe it’s just the angle (i.e., perspective..:)
Winners of the Blindspots analytical competition, CIP-I, Europe April 2017. From left to right: Olivier Hollesen from DONG O&G, Lynn Guinn from Cargill, Guy Bartram from VMWare.
Winners of the CIP-I Cross-Competitor Analytical Competition Europe April 2017
From left to right: Filippo Basso Ricci from Philips Lighting, Christian Mendez from Irdeto, Guy Bartram from VMWare, and Olga Menukhin from PRA World Ltd.
The real winners of course are their companies, who get highly trained CIPs rather than human search engines..:)
By Dr. Ben Gilad, ACI Faculty
I am typically a negative person. Well, not in my mind– I of course think I am a realist. But I hardly find reasons to celebrate in my field of competitive intelligence, until recently.
Following the publication of my Pharma Executive’s post, I received three calls from Pharma companies […]